Đang chuẩn bị liên kết để tải về tài liệu:
Pharmaceutical Substances Syntheses, Patents, Applications - Part 91

Pharmaceutical Substances Syntheses, Patents, Applications - Part 91. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Fluoxetine F 901 Reference s a. DE2500 110 Lilly appl. 3.1.1975 USA-prior. 10.1.1974 . US 4018 895 Lilly 19.4.1977 USA-prior. 10.1.1974 . US 4 194 009 Lilly 18.3.1980 USA-prior. 15.9.1976 . US 4 314 081 Lilly 2.2.1982 USA-prior. 10.1.1974 . US 4 584 404 Lilly 22.4.1986 USA-prior. 24.10.1983 25.1.1978 10.1.1974 . b US 5 847 214 Laporte Organics USA-prior. 7.7.1997 . c ES 2 103 680 Lilly appl. 3.8.1995 . d US 2760243 Albemarle Corp. USA-prior. 25.7.1997 . e ES 210 654 Lilly appl. 24.7.1995 . f EP 529 842 TevaPharm. appl. 6.8.1992 IL-prior. 27.8.1991 alternative synthesis EP391 070 Orion appl. 1.3.1990 FI-prior. 3.3.1989 . EP 380 924 E. Magnone appl. 8.1.1990 I-prior. 10.1.1989 . WO9 906 362 Albemarle Corp. appl. 4.8.1998 USA-prior. 4.8.1997 . W0 9 856 753 Albemarle Corp. appl. 12.6.1998 USA-prior. 12.6.1997 . ES 2 120 368 Almirall Prodesfarma 16.10.1998 appl. 14.6.1996 . EP529 842 TevaPharm. appl. 6.8.1992 IL-prior. 27.8.1991 . EP617006 PlivaD. appl. 4.2.1994 HR-prior. 5.2.1993 . ES 2 101 655 Lilly prior. 28.7.1995 . ES 2 101 654 Lilly prior. 24.7.1995 . ES2 101 650 Lilly prior. 29.6.1995 . I W0 9 811 054 Egis Gyogyszergyar appl. 10.9.1997 HU-prior. 10.9.1996 . US 5 760 243 Albemarle Corp. 2.6.1998 appl. 25.7.1996 . ES 2 103 680 Lilly S. A. 16.9.1997 appl. 3.8.1995 . ES2 103 681 Lilly 16.9.1997 appl. 19.9.1995 . t synthesis of enantiomers i US4950 791 H.C. Brown 21.8.1990 prior. 12.6.1989 30.3.1988 . US4918 242 Aldrich 17.4.1990 prior. 12.6.1989 30.3.1988 . US 4 918 207 Aldrich 17.4.1990 prior. 12.6.1989 30.3.1988 . fluoxetine chiral process from benzoylpropionic acid US 5 936 124 Sepacor Inc. appl. 22.6.1998 . treatment of nicotine withdrawal symptoms US4940585 W. E. Hapworth 10.7.1990 appl. 17.2.1989 . treatment of appetite and mood disturbances WO 8 903 692 MIT appl. 21.10.1988 USA-prior. 15.9.1988 22.10.1987 . antidiabetic combination EP 294 028 Lilly appl. 29.4.1988 USA-prior. 4.5.1987 . pharmaceutical formulation EP 693 281 Lilly appl. 17.7.1995 E-prior. .